GULDSMED CLAUSEN IVS: Financial statements 2019
CVR: 35857540
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GULDSMED CLAUSEN IVS (CVR 35857540) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,684 and a net result of DKK -1,684 compared with DKK 1,067 the year before. Equity in the 2019 report amounted to DKK 133. The solvency ratio was 13.9%.
- Gross Profit
- DKK -1,684
- Profit/Loss
- DKK -1,684
- Equity
- DKK 133
- Total Assets
- DKK 956
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -2K | -2K | 133 | - |
| 2018 | 18K | 1K | 1K | 2K | - |
| 2017 | 29K | 6K | 4K | 750 | - |
| 2016 | 38K | 8K | 1K | -3K | - |
| 2015 | 34K | 7K | 7K | -4K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GULDSMED CLAUSEN IVS has published its annual report for 2018. Revenue came to DKK 18,281, and the net result was DKK 1,067.
About GULDSMED CLAUSEN IVS
GULDSMED CLAUSEN IVS was a Danish company of the type Iværksætterselskab based in Aabenraa, founded in 2014. The company has been dissolved on 19 June 2020. The company was registered under the industry Uoplyst. In 2019, the company reported a gross profit of DKK -1,684 and a net result of DKK -1,684 compared with DKK 1,067 the year before. Equity in the 2019 report amounted to DKK 133.
